Cargando…

Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites

PURPOSE: The aim was to compare late-time extrapolation of plasma clearance (CL) from Tikhonov adaptively regularized gamma variate fitting (Tk-GV) and from mono-exponential (E1) fitting. METHODS: Ten (51)Cr-ethylenediaminetetraacetic acid bolus IV studies in adults—8 with ascites—assessed for liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wesolowski, Carl Adam, Ling, Lin, Xirouchakis, Elias, Burniston, Maria T., Puetter, Richard C., Babyn, Paul S., Giamalis, Ioannis G., Burroughs, Andrew K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218286/ https://www.ncbi.nlm.nih.gov/pubmed/21881927 http://dx.doi.org/10.1007/s00259-011-1887-9

Ejemplares similares

Tikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers
por: Wesolowski, Carl A., et al.
Publicado: (2010)

The early plasma concentration of (51)Cr-EDTA in patients with cirrhosis and ascites: a comparison of three models
por: Wanasundara, Surajith N., et al.
Publicado: (2015)

Variational regularization for systems of inverse problems: Tikhonov regularization with multiple forward operators
por: Huber, Richard
Publicado: (2019)

Influence of the Tikhonov Regularization Parameter on the Accuracy of the Inverse Problem in Electrocardiography
por: Wang, Tiantian, et al.
Publicado: (2023)

Tikhonov regularization of a second order dynamical system with Hessian driven damping
por: Boţ, Radu Ioan, et al.
Publicado: (2020)

Considering New Regularization Parameter-Choice Techniques for the Tikhonov Method to Improve the Accuracy of Electrocardiographic Imaging
por: Chamorro-Servent, Judit, et al.
Publicado: (2019)

Accurate and precise plasma clearance measurement using four (99m)Tc-DTPA plasma samples over 4 h
por: Wanasundara, Surajith N., et al.
Publicado: (2016)

Computation of distribution of relaxation times by Tikhonov regularization for Li ion batteries: usage of L-curve method
por: Paul, T., et al.
Publicado: (2021)

A New Hybrid Inversion Method for 2D Nuclear Magnetic Resonance Combining TSVD and Tikhonov Regularization
por: Landi, Germana, et al.
Publicado: (2021)

Surgical Treatment of Cirrhotic Ascites
Publicado: (1927)

Ayurvedic management of cirrhotic ascites
por: Aswathy, G., et al.
Publicado: (2016)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

A Metabolomic Analysis of Cirrhotic Ascites
por: Beyoğlu, Diren, et al.
Publicado: (2022)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Management of refractory cirrhotic ascites: challenges and solutions
por: Fukui, Hiroshi, et al.
Publicado: (2018)

Current approaches to the management of patients with cirrhotic ascites
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2019)

Association of serum sodium and 24-hour urinary sodium level with the severity and complications of ascites in cirrhotic patients
por: Islam, Susmita, et al.
Publicado: (2023)

A gamma-distribution convolution model of (99m)Tc-MIBI thyroid time-activity curves
por: Wesolowski, Carl A., et al.
Publicado: (2016)

Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs
por: Wesolowski, Carl A., et al.
Publicado: (2019)

Artifact removal in the contour areas of SAXS-CT images by Tikhonov-L1 minimization
por: Ogawa, Hiroki, et al.
Publicado: (2021)

The Evaluation of Serum Ascites Albumin Gradient and Portal Hypertensive changes in Cirrhotic Patients with Ascites
por: Shahed, Forhad Hossain Md, et al.
Publicado: (2016)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Bacteriologic study of cirrhotic patients with non-neutrocytic ascites
por: Dabiri, Hossein, et al.
Publicado: (2014)

Alteration of the serum microbiome composition in cirrhotic patients with ascites
por: Santiago, Alba, et al.
Publicado: (2016)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites
por: Metwally, Khaled, et al.
Publicado: (2018)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

Undifferentiated shock in a cirrhotic patient: Ascites matters
por: Xenou, Antigoni, et al.
Publicado: (2021)

The Role of Serum Procalcitonin Levels in Predicting Ascitic Fluid Infection in Hospitalized Cirrhotic and Non-cirrhotic Patients
por: Cekin, Yesim, et al.
Publicado: (2013)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving
por: Bloom, Patricia P., et al.
Publicado: (2021)

Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites
por: Chen, Yanfei, et al.
Publicado: (2018)

Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011)

The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX(©) Catheter
por: Reinglas, Jason, et al.
Publicado: (2016)

Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians
por: Gallo, Andrea, et al.
Publicado: (2020)

Consensus care recommendations for alfapump(®) in cirrhotic patients with refractory or recurrent ascites
por: Aagaard, Niels Kristian, et al.
Publicado: (2022)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
por: Hosui, Atsushi, et al.
Publicado: (2021)

Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis
por: El Gohary, Ahmed M., et al.
Publicado: (2021)

Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites
por: Hirooka, Masashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oeg31fstmf4euh5qv7ltnnl0so